← All organizations
Highest phase reached
Phase 3
First clinical trial
Jun 1, 2010Last known activity
Sep 30, 2025
Timeline
No events for the selected filters.
Drugs by trial phase (22 distinct, 6 trials)
Phase 3 (1 own, 0 via acquisition)
Phase 2 (7 own, 0 via acquisition)
Indications
Recent trials (6)
- NCT06942039Lead sponsorEarly Phase 1Sep 30, 2025
- NCT06666348Lead sponsorPhase 1/Phase 2Jan 1, 2025
- NCT06208657CollaboratorPhase 1/Phase 2Jul 10, 2024
- NCT02303028CollaboratorPhase 1/Phase 2Mar 1, 2015
- NCT01858155Lead sponsorPhase 1May 1, 2013
- NCT01135550CollaboratorPhase 3Jun 1, 2010
Details
- Last known activity
- Sep 30, 2025